Chuhern Hwang

Company: Wayfinder Biosciences

Job title: Co-Founder & Head of Drug Discovery

Seminars:

Discovery of Selective RNA Binders Through a Quantitative High Throughput Primary Biochemical Screen 3:00 pm

Utilizing biophysical design methods to develop RNA switch-based sensors to identify compounds that modulate target RNA structure Rapidly generating highly quantitative datasets on binding and selectivity of compound libraries against RNA targets Leveraging machine learning models trained on highly quantitative HTS data to generate novel binders for RNAs through virtual screening of millions of moleculesRead more

day: Conference Day One